Heading 1
Heading 2
Heading 3
Heading 4
This is Signal by Foresight, the weekly chemical regulation newsletter dedicated to giving you everything you need to know in a 5-minute read or less. You are receiving this email because you registered for a recent webinar.
- This is a test
- This is a test
- This is a test
- This is a test
- This is a test
- This is a test
🔍 The Headlines in Focus
🌍 Public Consultation for Stockholm Convention Updates
The Stockholm Convention has launched a public consultation to update its guidelines on best practices for managing persistent organic pollutants (POPs). Key areas under review include the production and use of UV-328, SCCPs, and PBDEs. Stakeholders are invited to submit feedback by 16 September 2024 to help refine these crucial environmental guidelines.
Read the full article
🧰 Asbestos and Mesothelioma: Deaths on the Decline
The latest Health and Safety Executive (HSE) report shows a slight but meaningful decline in mesothelioma deaths in Great Britain, with 2,257 cases in 2022, down from 2,290 in 2021. This decline, primarily among men, reflects reduced asbestos exposure since the 1980s. The report projects a continued gradual decrease in deaths, highlighting the long-term effects of asbestos regulations.
Read the full article
🚨 New Regulatory Measures for Aziridine Compounds
The European Chemicals Agency (ECHA) has identified 14 aziridine compounds, commonly used in adhesives and textiles, as posing significant health risks, including carcinogenicity and mutagenicity. ECHA proposes stringent regulatory actions, such as banning these substances in consumer products and setting strict occupational exposure limits to protect workers and the environment.
Read the full article
⚠️ N-Methylaniline Poses Cancer and Genetic Risks
A new report from Poland’s Bureau for Chemical Substances highlights the potential carcinogenic and mutagenic risks of N-methylaniline, an additive in gasoline. The report suggests stricter regulations, including revised exposure assessments and possible labeling as a suspected carcinogen and mutagen to protect workers and consumers from high-risk exposure.
Read the full article
⚖️ Evonik Appeal Dismissed by ECHA Board of Appeal
The ECHA Board of Appeal has dismissed Evonik Operations GmbH’s challenge to a decision requiring additional toxicity data for a chemical substance. The ruling upholds ECHA’s strict enforcement of REACH compliance, emphasising the importance of thorough testing for chemical safety, including histopathological examinations to determine organ toxicity levels.
Read the full article
